PTH receptor

1
Assets
1
Companies

Target Biology

Competitive Landscape

Asset Company Stage Mechanism Lead Indication Ownership
Palopegteriparatide_YORVIPATH_TransCon_PTH ASND Approved Prodrug of PTH (1-34) that provides active PTH within physiological range for 24 hours per day through transient conjugation technology

Companies

← Back to All Targets